Milestone Pharmaceuticals Inc.
NASDAQ: MIST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joseph G. Oliveto
- Employees
- 33
- Headquarters
- Montreal, Canada
- IPO year
- 2019
- Market cap
- $109.1M
- Website
- https://www.milestonepharma.com
Loading MIST…
Loading profile data…Frequently asked questions about MIST
What does Milestone Pharmaceuticals Inc. (MIST) do?
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxys...
Where does MIST trade?
Milestone Pharmaceuticals Inc. (MIST) trades on the NASDAQ Global Select.
What sector is MIST in?
Milestone Pharmaceuticals Inc. (MIST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Milestone Pharmaceuticals Inc.?
Joseph G. Oliveto is the chief executive officer of Milestone Pharmaceuticals Inc. (MIST).
Where is Milestone Pharmaceuticals Inc. headquartered?
Milestone Pharmaceuticals Inc. is headquartered in Canada.
Does MIST pay a dividend?
Milestone Pharmaceuticals Inc. (MIST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MIST go public?
Milestone Pharmaceuticals Inc. (MIST) completed its initial public offering in 2019.